Eukaryotic Translation Initiation Factor EIF4G2 Opens Novel Paths for Protein Synthesis in Development, Apoptosis and Cell Differentiation
Overview
Authors
Affiliations
Protein translation is a critical regulatory event involved in nearly all physiological and pathological processes. Eukaryotic translation initiation factors are dedicated to translation initiation, the most highly regulated stage of protein synthesis. Eukaryotic translation initiation factor 4G2 (eIF4G2, also called p97, NAT1 and DAP5), an eIF4G family member that lacks the binding sites for 5' cap binding protein eIF4E, is widely considered to be a key factor for internal ribosome entry sites (IRESs)-mediated cap-independent translation. However, recent findings demonstrate that eIF4G2 also supports many other translation initiation pathways. In this review, we summarize the role of eIF4G2 in a variety of cap-independent and -dependent translation initiation events. Additionally, we also update recent findings regarding the role of eIF4G2 in apoptosis, cell survival, cell differentiation and embryonic development. These studies reveal an emerging new picture of how eIF4G2 utilizes diverse translational mechanisms to regulate gene expression.
Molina Molina E, Bech-Serra J, Franco-Trepat E, Jarne I, Perez-Zsolt D, Badia R Nat Commun. 2025; 16(1):1087.
PMID: 39920115 PMC: 11805953. DOI: 10.1038/s41467-025-56151-y.
Optimized circular RNA vaccines for superior cancer immunotherapy.
Yu H, Wen Y, Yu W, Lu L, Yang Y, Liu C Theranostics. 2025; 15(4):1420-1438.
PMID: 39816687 PMC: 11729565. DOI: 10.7150/thno.104698.
Powell A, Velleman S, Strasburg G, Abrahante Llorens J, Reed K Front Physiol. 2024; 15:1476487.
PMID: 39359572 PMC: 11445135. DOI: 10.3389/fphys.2024.1476487.
de Almeida Saraiva H, Sangalli J, Alves L, da Silveira J, Meirelles F, Perecin F Anim Reprod. 2024; 21(2):e20230101.
PMID: 39021501 PMC: 11253787. DOI: 10.1590/1984-3143-AR2023-0101.
Non-canonical mRNA translation initiation in cell stress and cancer.
Mahe M, Rios-Fuller T, Katsara O, Schneider R NAR Cancer. 2024; 6(2):zcae026.
PMID: 38828390 PMC: 11140632. DOI: 10.1093/narcan/zcae026.